Category: Business Development

The best outbound converts at multiples of the average outbound. The reason isn’t a better subject line or a cleaner cadence. It’s that the best outbound doesn’t feel like outbound.

Average outbound feels like a template: generic opener, vague value prop, soft CTA, forgettable sign-off. Even when personalized with first name and company name, it reads as mass-produced. Because it is.

High-converting outbound reads like a thoughtful note from someone who happens to think the recipient would find it useful. The underlying content may still be structured — the opener, the value prop, the ask are all there — but the execution is specific enough that the recipient can’t detect the template.

The Specificity Unlock

Specificity is the single biggest lever in outbound. More than sequence length, more than channel mix, more than send time.

Specificity means your outbound references something particular about the recipient: a recent announcement they made, a project they’re known for, a specific challenge facing their company, a connection to someone in their network. It signals you did the work to understand them before reaching out.

Specificity is expensive. It takes 10 to 20 minutes per prospect to do properly. Which is why most outbound avoids it — the volume game incentivizes speed, and the volume game is where most companies’ outbound motions live.

The companies winning on outbound have flipped the math. They send less, spend more per outreach, and convert at rates that make the math work in their favor.

Three Specificity Moves

1. Open with something only you would know about them.
Not “I saw you’re the VP of Operations.” Everyone knows that. Something like “I noticed your team published a post about X last month — the point about Y was counterintuitive and I’ve been thinking about it since.” The recipient can’t tell if you’re a thoughtful stranger or a careful planner. They take the meeting either way.

2. Make the value prop relevant to their specific context.
Not “we help companies like yours.” “We help operators in your industry solve the problem where Z happens.” The closer you can get to their actual situation, the less the email feels like outbound.

3. Make the ask specific and low-friction.
Not “15 minutes to discuss.” Something like “I could share the pattern I mentioned — would a 20-minute call next Thursday or Friday work?” Give them options. Give them agency. Make it easy to say yes.

What It Looks Like in Practice

Before specificity:

Hi [First Name], I came across your profile and thought we’d be a good fit. We help companies like [Company] reduce costs and improve efficiency. Would you have 15 minutes to chat?

After specificity:

Hi Maria — saw the announcement last week about your team’s expansion into the Atlanta market. Curious whether the same infrastructure questions that hit you in Dallas are coming up again, because we’ve seen a specific pattern play out in southeast rollouts. Happy to walk through it if useful — 20 minutes, either Thursday afternoon or Friday morning work for me.

The second one takes 15 minutes to write. It converts at somewhere between 5 and 15x the first.

Volume Isn’t the Answer

The reps I’ve watched crush outbound run lower-volume, higher-specificity sequences. They send 50 to 75 thoughtful outreaches per week instead of 300 templated ones. Their book looks different. Their activity metrics look worse. Their bookings look unreasonable.

Management teams that measure outbound on volume metrics — emails sent, connections made, dials placed — are running a factory that optimizes for the wrong output. The reps who hit quota in those environments are the ones who game the volume metrics just enough while actually spending their real time on a smaller list.

The Test

For your next ten outbound messages, spend 15 minutes on each. Reference something specific. Make the ask easy. Send them.

Track the response rate against your normal cadence. You’ll have your answer about which math is right for your motion within two weeks.

---

Outbound isn’t dying. Template outbound is. The operators who send fewer, better messages are taking market share from the ones still running the volume play.

That shift is quiet, but it’s finished — or it’s finishing, in most markets. The question is which side of it you’re on.

The mark of a mature BD operator is not how many deals they pursue. It’s how many they correctly walk away from.

Most sellers are trained to qualify in — find reasons to keep a deal alive, extend pipeline, defer the hard conversation. Top sellers qualify out — they identify bad-fit deals early, end the cycle gracefully, and reclaim the time for deals that can actually close.

This is counterintuitive in organizations that measure pipeline coverage ratios. If your quota coverage target is 3x, and you’re sitting at 2.5x, qualifying out feels like throwing away pipeline you need.

That’s the wrong math.

The Right Math

A bad-fit deal has a low probability of closing, a long cycle, high support costs during the cycle, and — if it does close — high churn risk because the product wasn’t actually a fit. The fully loaded cost of pursuing it (seller time, SE time, deal desk time, legal time, executive time) often exceeds the contribution margin even if it closes.

The seller who runs 3x coverage with 40% bad-fit deals is less productive than the seller who runs 1.8x coverage with 15% bad-fit deals.

Quota coverage is a metric. Quota achievement is the point.

Three Signals to Qualify Out

1. The champion can’t articulate the consequence of not changing.
If the customer can’t tell you, specifically, what breaks if they don’t buy — either the problem isn’t urgent or your champion isn’t the right person. In consulting, this was the reliable tell. Prospects who could not articulate what happened if they didn’t engage were prospects who would spend six months “evaluating” and never sign.

2. The timeline doesn’t match the process.
If the customer says they want to sign in 30 days but their org requires 90 days of legal review and procurement, the timeline is fiction. You have two options: reset the timeline to reality (which some customers will do, and that’s a good sign) or accept that the cycle will run longer than forecast (and price your forecasting accordingly).

3. The deal is being shopped.
Sometimes the customer has already decided — but needs a second quote to satisfy procurement. You’re the stalking horse. The tell: they move fast, they’re only asking pricing questions, they aren’t asking about implementation, and your champion isn’t really your champion. If the customer can’t introduce you to at least one other stakeholder, you’re a reference quote.

How to Qualify Out Without Burning the Relationship

Qualifying out doesn’t mean disappearing. The best sellers I’ve watched qualify out with precision:

• They name the mismatch specifically: “I don’t think this is the right fit right now because X.”
• They offer an alternative: “Here’s who I’d actually recommend you look at.”
• They leave the door open: “If X changes in the next 6 to 12 months, call me.”

This is the move that builds durable reputation. Customers remember the rep who walked away from their deal honestly more than the one who pushed through and then didn’t deliver. Six months later, the customer whose circumstances changed will call you first.

In medtech, I watched a senior rep turn down a hospital deal because the procurement calendar didn’t align with the clinical urgency. The hospital’s own clinician thanked her for the honesty. Eighteen months later, when the procurement cycle reset, they closed a larger deal because the trust had been deposited.

The Diagnostic

Pull your pipeline. For each deal above your minimum threshold, ask three questions:

1. Can the champion articulate the cost of not changing?
2. Does the customer’s stated timeline match their actual process?
3. Am I the second quote?

If you get “no” on any two of those for a given deal, that deal should come out of your forecast. You don’t have to kill it — but you shouldn’t be committing it to your board.

---

Qualifying out isn’t weakness. It’s the discipline that makes the in-deals close.

The sellers who hit their number consistently are not the ones with the most pipeline. They’re the ones with the cleanest pipeline. That cleanliness comes from the willingness to say, early and honestly, “this one isn’t real.”

By the time you’re on a discovery call, a significant portion of the outcome has already been decided. Not by you. By how much you know walking in.

The pre-discovery call is the work you do before the customer ever sees you. Most reps skip it, run a generic discovery motion, and wonder why their win rates look nothing like their top performers’.

Here’s what actually goes into a proper pre-discovery routine:

Read Three of Their Recent Public Signals

If they’re public, their earnings calls are a gold mine. If they’re private, their website press section tells you what they want the world to know. What do they say is their priority? What language do they use? What numbers do they cite?

Walking into discovery able to say “I noticed on your last earnings call the COO emphasized X — is that informing what we’re talking about today?” changes the tenor of the meeting immediately. You’ve moved from vendor-asking-questions to peer-who-did-the-work.

Know Their Competitors Better Than They Do

In medtech, this meant knowing which clinical study was published about the competitor’s device in the last six months. In telecom, which regulatory filing their competitor just made. In construction, which project their competitor just won.

Competitive awareness is not trying to sell against competitors in the first meeting — it’s showing the customer that you understand their market as well as they do. That’s a trust signal.

Know the Person

LinkedIn, a 5-minute Google, any podcast or interview they’ve done. You’re not trying to become their biographer. You’re looking for three things: what they’re known for, what they’ve said publicly about their current priorities, and who in your network might know them.

The last one is the most valuable. A pre-discovery call where you realize you share a past colleague with the prospect changes the first meeting’s entire register. Reach out to that colleague before the meeting — not during — to confirm what you think you know.

Map Their Org

Before the call, sketch what you think the buying committee looks like. You’ll be wrong — that’s fine. Being wrong with a specific hypothesis is infinitely better than being blank. The hypothesis lets you ask sharper questions: “I’d guess procurement gets involved at some threshold — is that right?”

Identify the Likely Silent Stakeholder

From industry pattern alone, you can usually guess who’s going to kill the deal late if you don’t manage them early. In medtech, probably IT or supply chain. In telecom, probably facilities or the network ops lead. In construction, probably the bonding company. In consulting, procurement.

Walking into discovery already hypothesizing who the silent stakeholder is lets you surface them in the first call instead of month three.

Pre-Write Your Hypotheses

The best discovery calls I’ve run — and the best I’ve watched others run — started with the seller walking in with three hypotheses: “Here’s what I think is happening. Here’s what I think is broken. Here’s what I think you’ve tried.”

Then the call becomes the customer correcting or confirming each one. That’s a consultation. It’s also wildly more efficient than asking open questions and taking notes.

---

The work takes 30 to 60 minutes per call. Most reps won’t do it because it’s unstructured and can’t be tracked in the CRM. Top reps will do it because the conversion delta is massive.

Three quality checks for your pre-discovery:

1. Can you tell the prospect something about their business they don’t expect you to know? If yes, you’ve done enough research. If no, keep going.

2. Do you have a specific hypothesis about why the meeting is happening now? Not the BANT version — the real version. Something changed, or they wouldn’t be talking to you. What was it?

3. Do you know one question you’re going to ask that they won’t have heard from another vendor? This is the question that makes you memorable.

The discovery call that starts with “So, tell me about your business” is almost always run by someone who didn’t do their pre-discovery. It’s a signal to the customer that the seller didn’t do the work.

Do the work before the meeting. Walk in already 40% of the way through discovery. The rest of the meeting becomes useful for both of you.

The best discovery call feels like a consultation. The worst feels like a deposition.

If you leave discovery with a clean qualification grid and nothing else, you didn’t do discovery. You did intake. Real discovery is a clinical exercise — you’re diagnosing the customer’s situation, not qualifying their BANT.

This is the mindset shift that separates sellers who win competitive deals from those who don’t. Interrogators ask questions to extract data. Diagnosticians ask questions to build understanding — both for themselves and for the customer.

Three diagnostic moves I use on every discovery call:

1. Symptom → Mechanism

Don’t just catalog what the customer says is broken. Understand why it’s broken. The symptom is “our team can’t scale.” The mechanism might be “we have no system for onboarding the fifth hire after the founder stops being in every interview.” Those are entirely different problems, and only one of them is something you can actually solve.

In consulting, this was the difference between a BD call that earned a follow-up and one that earned a project. Symptom-level conversations got polite nods. Mechanism-level conversations got the customer to say “say more about that” — and that’s when real discovery starts.

2. Diagnosis → Prognosis

Once you understand the mechanism, help the customer see what happens if they don’t fix it. Not FUD — just consequence tracing. “If you keep onboarding this way, what happens when you hire three more?” “If the HL7 issue doesn’t get resolved before go-live, what does the first week of production look like?”

Medtech reps who could walk clinicians through the prognosis of not changing — the downstream clinical, operational, and financial costs — closed deals the competition couldn’t touch. Not because they were more aggressive. Because they were more useful.

The customer often hasn’t traced the consequences themselves. They see the symptom. They haven’t sat with what happens if it compounds for another two quarters. Helping them sit with it, calmly and clinically, is the most valuable thing you can do in a first meeting.

3. Prognosis → Urgency

Why now? This is the question that separates deals that close from deals that slip.

If the prognosis is bad but not urgent, the deal will slip indefinitely. If the prognosis is bad and there’s a forcing function — a contract expiry, a compliance deadline, a budget cycle, a competitor moving — the deal will close.

Good diagnosticians find the forcing function. Great ones help the customer see it when the customer didn’t. In telecom, the forcing function was often a build-out schedule. In construction, a bonding or insurance deadline. In medtech, a regulatory filing or a surgical volume ramp. In consulting, a board meeting or an earnings call. The forcing function is always there — it’s just rarely top of mind.

---

The way to tell whether you’re doing diagnostic discovery or interrogation discovery: count the ratio of qualifying questions to diagnostic questions in your recorded calls.

Qualifying questions sound like: “What’s your timeline?” “Who else is involved?” “What’s your budget?”

Diagnostic questions sound like: “Walk me through the last time this broke.” “What have you tried that didn’t work?” “If this stays broken, what breaks next?”

Healthy ratio is roughly 1 qualifying question per 3 diagnostic questions. Most reps run 3:1 the other direction — they front-load qualifying, which is why their discovery feels like intake.

The tactical benefit of diagnostic discovery is better data. The strategic benefit is that the customer leaves the call feeling like they understand their own situation better than before you showed up.

That’s trust. That’s why they take the next meeting. That’s why they refer you.

Audit one recorded discovery call this week. Count the ratios. If you’re interrogation-heavy, rewrite your opening five questions. You’ll see the difference in win rate within a quarter.

Most enterprise reps think of “the champion” as a single person — usually the one who said “I love this” on the first call. That’s a dangerous simplification. Your champion isn’t one person. It’s a map of archetypes, and winning the deal depends on managing all of them.

Here’s the map I use on every complex deal:

The Champion. The person who wants the deal to happen and will spend political capital to make it so. Already sold, by definition. The deal is not won through this person — it’s won through the three below.

The Mobilizer. The person who coordinates stakeholders across the buying committee. They may not own the outcome but they own the process. Matt Dixon’s research made this archetype famous for a reason: in complex B2B, the Mobilizer is often who actually gets the deal moving internally.

The Skeptic. The person who needs to be converted before sign-off. Not hostile — analytical. They have legitimate concerns about risk, cost, or integration. They will ask the hard questions your champion won’t, and your job is to have answers before the question is asked.

The Blocker. The person who will kill the deal if not managed. Sometimes their job is to say no (procurement, legal). Sometimes they have a competing priority or a preferred alternative. Always: they exist, and they’re dangerous when invisible.

In medtech, I’ve watched this play out on nearly every deal: the clinical champion is already sold, the department head is the skeptic (worried about workflow disruption), supply chain is the blocker (concerned about vendor consolidation), and the COO is the mobilizer coordinating across all of them. Miss any one and you lose the deal.

In telecom, the pattern looks different in titles but identical in structure: the CTO is the champion, the network ops lead is the skeptic, finance is the blocker, and the procurement lead is the mobilizer.

In construction, the GC is the champion, the owner’s rep is the skeptic, the bonding company is the blocker, and the project manager is the mobilizer.

In consulting, the sponsoring partner is the champion, the COO is the skeptic, procurement is the blocker, and the engagement manager is the mobilizer.

The titles change. The roles don’t.

The failure mode is almost always the same: the rep builds a strong relationship with the champion, ignores or underinvests in the other three, and gets surprised when the deal stalls at decision. The deal didn’t stall — the rep just wasn’t talking to the people who actually moved it.

Three moves that separate operators who can map champions from those who can’t:

1. Name every stakeholder, not just titles. “VP of Operations” is not a name. If you can’t name the person, you don’t know the deal. Titles suggest you’ve done research. Names prove you’ve had conversations.

2. Classify each stakeholder into the map. Champion, Mobilizer, Skeptic, or Blocker. If everyone is a champion, you haven’t done the work — real buying committees always have skeptics and blockers. The fact that you haven’t identified any means you haven’t gone deep enough.

3. Build an engagement plan per archetype. The champion needs ammunition (data, case studies, answers to hard questions). The mobilizer needs process clarity (timelines, decision paths, next steps). The skeptic needs evidence (references, proof points, risk mitigation). The blocker needs to either be converted or isolated — but they cannot be ignored.

The good sellers I’ve worked alongside always knew exactly where every stakeholder sat on the map. The mediocre ones had a single champion and hoped for the best.

Pull your top five deals right now. For each, sketch the map. Name names under each archetype. You’ll find something uncomfortable — usually two or more blockers you haven’t engaged, or a skeptic you’ve been avoiding because the conversation would be hard.

That’s the work. That’s the difference between a pipeline and a forecast.